Description:
Unlock valuable insights and data points for strategic business planning with Kalorama Information’s comprehensive report, The World Liquid Biopsy Market, 2021. This report delves into various facets of the liquid biopsy market, providing a detailed analysis that is crucial for stakeholders in the healthcare and diagnostics industry.
Market Highlights
- Research vs. Clinical Liquid Biopsy: Examine the differences and applications of liquid biopsy in research and clinical settings.
- Regional Market Analysis: Understand the market dynamics and opportunities for liquid biopsy across different regions.
- Analyte-Specific Markets: Explore the market segmentation by types of analytes, including CTC-based, ctDNA-based, EV and exosome-based, multi-analyte, and other liquid biopsy methods.
In-Depth Market Segmentation
- CTC-based Liquid Biopsy: Market size and growth trends for circulating tumor cell (CTC) assays.
- ctDNA-based Liquid Biopsy: Insights into the market for circulating tumor DNA (ctDNA) tests.
- EV and Exosome-based Liquid Biopsy: Analysis of the market for extracellular vesicle (EV) and exosome-based liquid biopsy.
- Multi-Analyte-based Liquid Biopsy: Detailed look into tests that assess multiple analytes.
- Other Liquid Biopsy Methods: Overview of additional liquid biopsy techniques and their market potential.
Cancer Type Analysis
- Liquid Biopsy Market by Type of Cancer: Focused insights on liquid biopsy applications for various cancers, including breast, lung, colorectal, ovarian, prostate, pan-cancer, and others.
Selected Liquid Biopsy Tests
- ctDNA-based Liquid Biopsy Tests in Development: Information on emerging ctDNA tests.
- Market-Available CTC-based Liquid Biopsy Tests, 2021: A review of currently available CTC tests.
- Multi-Analyte Liquid Biopsy Tests, 2021: Highlights of tests assessing multiple analytes.
Clinical Applications and Benefits
- Early Detection and Diagnosis: The role of liquid biopsy in early cancer detection and screening.
- Alternative Testing Methods: Use of liquid biopsy when tissue biopsy is challenging or impossible.
- Therapy Personalization and Monitoring: How molecular characterization through liquid biopsy aids in selecting and adjusting therapies.
- Disease Monitoring: The importance of liquid biopsy in observing disease progression, tumor evolution, residual disease, and early recurrence detection.
- Prognosis: Utilizing liquid biopsy for disease prognosis.
For further details and to purchase directly, please contact us.
Sample Report: A sample is available as a PDF upon request.
Table: Global Liquid Biopsy Market Forecast, by Region, 2021-2026 ($ millions)
| Region | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | CAGR ’21 – ’26 |
| North America | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | XX% |
| Europe | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | XX% |
| Asia Pacific | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | XX% |
| Rest of World | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | XX% |
| WORLD | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | XX% |
Source: Kalorama Information
